Thailand

 

Overall revenues up at Bupa – but Bupa Global’s profits decline

Overall revenues at Bupa are up according to its half year results – with only Bupa Global notably blotting the copybook with a decline in profits. Here is what Bupa had to say to Healthcare Europa and Nova about those Bupa Global figures - and their views on the thinking behind the recent sale of Bupa Home Healthcare to Celesio in the UK - together with a summary of the half-year report.
August 17, 2016

Report: East Africa – rising slowly, steadily, surely

The private sector plays a key role in healthcare delivery across Africa. While the East African economies of Kenya, Uganda and Tanzania are experiencing relatively high growth, public sector healthcare facilities are sub-standard. The private sector already accounts for nearly half of total expenditure and is coming up with innovative and affordable ways to provide services. Here we look at the main groups and track trends.
February 11, 2016

Report: All listed healthcare service companies active in Emerging Markets

Here we present the first comprehensive list of all 57 quoted healthcare service companies which are active in Emerging Markets. The list includes companies headquartered in the Developed World, who have interests in Emerging Markets, such as Air Liquide, Fresenius or Ramsay Health Care, as well as quoted operators from the region, such as IHH, Apollo or Integrated Diagnostic Holdings. It covers everyone from Chilean hospitals to Egyptian lab operators and from NYSE quoted operators in China to big groups in Malaysia and Indonesia.
September 28, 2015

Senior Assist to triple beds in Chile

Senior Assist, the Belgian elderly care group, expects its nursing home business in Chile to triple to 1,500 beds by 2018. The group has also opened homes in Turkey and Uruguay and is looking at Colombia, Russia and Thailand. We talk to Roderick Peters, CEO of Senior Assist Latin America about the Latin America market.
September 22, 2015

Bupa growth strongest in emerging markets

The global healthcare group Bupa, experienced rapid growth in markets as diverse as Saudi Arabia, Hong Kong and Chile. It continues to make acquisitions across emerging markets, as well as launching new healthcare insurance products and distribution agreements. Global sales rose 7% to £4,916m from the first half of 2014, at constant exchange rates (CER), or 3% taken at actual exchange rates (AER). Underlying profit before taxation hit £253.3m, an increase of 2% at CER, or a fall of 3% at AER. In a wide-ranging interview, CEO Stuart Fletcher, spoke to Healthcare Nova about the results and Bupa’s future plans.
August 7, 2015
Newer posts
Older posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us